Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 46 entries
Sorted by: Best Match Show Resources per page
Update on the Management of Diabetic Neuropathy.

Diabetes spectrum : a publication of the American Diabetes Association

Ang L, Cowdin N, Mizokami-Stout K, Pop-Busui R.
PMID: 30140138
Diabetes Spectr. 2018 Aug;31(3):224-233. doi: 10.2337/ds18-0036.

No abstract available.

Cite
Ang L, Cowdin N, Mizokami-Stout K, et al. Update on the Management of Diabetic Neuropathy. Diabetes Spectr. 2018;31(3):224-233doi: 10.2337/ds18-0036.
Ang, L., Cowdin, N., Mizokami-Stout, K., & Pop-Busui, R. (2018). Update on the Management of Diabetic Neuropathy. Diabetes spectrum : a publication of the American Diabetes Association, 31(3), 224-233. https://doi.org/10.2337/ds18-0036
Ang, Lynn, et al. "Update on the Management of Diabetic Neuropathy." Diabetes spectrum : a publication of the American Diabetes Association vol. 31,3 (2018): 224-233. doi: https://doi.org/10.2337/ds18-0036
Ang L, Cowdin N, Mizokami-Stout K, Pop-Busui R. Update on the Management of Diabetic Neuropathy. Diabetes Spectr. 2018 Aug;31(3):224-233. doi: 10.2337/ds18-0036. PMID: 30140138; PMCID: PMC6092893.
Copy Download .nbib Format: NLM
Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients.

Journal of diabetes investigation

Pop-Busui R, Backlund JC, Bebu I, Braffett BH, Lorenzi G, White NH, Lachin JM, Soliman EZ.
PMID: 34309223
J Diabetes Investig. 2022 Jan;13(1):125-133. doi: 10.1111/jdi.13635. Epub 2021 Aug 14.

AIMS/INTRODUCTION: Cardiovascular autonomic neuropathy (CAN) is a predictor of cardiovascular disease and mortality. Cardiovascular reflex tests (CARTs) are the gold standard for the diagnosis of CAN, but might not be feasible in large research cohorts or in clinical care....

Cite
Pop-Busui R, Backlund JC, Bebu I, et al. Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients. J Diabetes Investig. 2021;13(1):125-133doi: 10.1111/jdi.13635.
Pop-Busui, R., Backlund, J. C., Bebu, I., Braffett, B. H., Lorenzi, G., White, N. H., Lachin, J. M., Soliman, E. Z. (2022). Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients. Journal of diabetes investigation, 13(1), 125-133. https://doi.org/10.1111/jdi.13635
Pop-Busui, Rodica, et al. "Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients." Journal of diabetes investigation vol. 13,1 (2022): 125-133. doi: https://doi.org/10.1111/jdi.13635
Pop-Busui R, Backlund JC, Bebu I, Braffett BH, Lorenzi G, White NH, Lachin JM, Soliman EZ. Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients. J Diabetes Investig. 2022 Jan;13(1):125-133. doi: 10.1111/jdi.13635. Epub 2021 Aug 14. PMID: 34309223.
Copy Download .nbib Format: NLM
Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetes.

Neurourology and urodynamics

Bakre S, Holt SK, Oerline M, Braffett BH, Pop-Busui R, Wessells H, Sarma AV.
PMID: 34672384
Neurourol Urodyn. 2022 Jan;41(1):323-331. doi: 10.1002/nau.24823. Epub 2021 Oct 21.

AIMS: Urinary incontinence (UI) in women is a dynamic condition with numerous risk factors yet most studies have focused on examining its prevalence at a single time. The objective of this study was to describe the long-term time course...

Cite
Bakre S, Holt SK, Oerline M, et al. Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetes. Neurourol Urodyn. 2021;41(1):323-331doi: 10.1002/nau.24823.
Bakre, S., Holt, S. K., Oerline, M., Braffett, B. H., Pop-Busui, R., Wessells, H., Sarma, A. V. (2022). Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetes. Neurourology and urodynamics, 41(1), 323-331. https://doi.org/10.1002/nau.24823
Bakre, Shivani, et al. "Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetes." Neurourology and urodynamics vol. 41,1 (2022): 323-331. doi: https://doi.org/10.1002/nau.24823
Bakre S, Holt SK, Oerline M, Braffett BH, Pop-Busui R, Wessells H, Sarma AV. Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetes. Neurourol Urodyn. 2022 Jan;41(1):323-331. doi: 10.1002/nau.24823. Epub 2021 Oct 21. PMID: 34672384.
Copy Download .nbib Format: NLM
Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetes.

Neurourology and urodynamics

Bakre S, Holt SK, Oerline M, Braffett BH, Pop-Busui R, Wessells H, Sarma AV.
PMID: 34672384
Neurourol Urodyn. 2022 Jan;41(1):323-331. doi: 10.1002/nau.24823. Epub 2021 Oct 21.

AIMS: Urinary incontinence (UI) in women is a dynamic condition with numerous risk factors yet most studies have focused on examining its prevalence at a single time. The objective of this study was to describe the long-term time course...

Cite
Bakre S, Holt SK, Oerline M, et al. Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetes. Neurourol Urodyn. 2021;41(1):323-331doi: 10.1002/nau.24823.
Bakre, S., Holt, S. K., Oerline, M., Braffett, B. H., Pop-Busui, R., Wessells, H., Sarma, A. V. (2022). Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetes. Neurourology and urodynamics, 41(1), 323-331. https://doi.org/10.1002/nau.24823
Bakre, Shivani, et al. "Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetes." Neurourology and urodynamics vol. 41,1 (2022): 323-331. doi: https://doi.org/10.1002/nau.24823
Bakre S, Holt SK, Oerline M, Braffett BH, Pop-Busui R, Wessells H, Sarma AV. Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetes. Neurourol Urodyn. 2022 Jan;41(1):323-331. doi: 10.1002/nau.24823. Epub 2021 Oct 21. PMID: 34672384; PMCID: PMC8738144.
Copy Download .nbib Format: NLM
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19.

Journal of the American Heart Association

Pan M, Vasbinder A, Anderson E, Catalan T, Shadid HR, Berlin H, Padalia K, O'Hayer P, Meloche C, Azam TU, Khaleel I, Michaud E, Blakely P, Bitar A, Huang Y, Zhao L, Pop-Busui R, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Reiser J, Eugen-Olsen J, Hayek SS.
PMID: 34889102
J Am Heart Assoc. 2021 Dec 21;10(24):e023535. doi: 10.1161/JAHA.121.023535. Epub 2021 Dec 10.

Background Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ACEi/ARB) is thought to affect COVID-19 through modulating levels of angiotensin-converting enzyme 2, the cell entry receptor for SARS-CoV2. We sought to assess the association between ACEi/ARB, biomarkers of...

Cite
Pan M, Vasbinder A, Anderson E, et al. Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19. J Am Heart Assoc. 2021;10(24):e023535doi: 10.1161/JAHA.121.023535.
Pan, M., Vasbinder, A., Anderson, E., Catalan, T., Shadid, H. R., Berlin, H., Padalia, K., O'Hayer, P., Meloche, C., Azam, T. U., Khaleel, I., Michaud, E., Blakely, P., Bitar, A., Huang, Y., Zhao, L., Pop-Busui, R., Loosen, S. H., Chalkias, A., Tacke, F., Giamarellos-Bourboulis, E. J., Reiser, J., Eugen-Olsen, J., Hayek, S. S. (2021). Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19. Journal of the American Heart Association, 10(24), e023535. https://doi.org/10.1161/JAHA.121.023535
Pan, Michael, et al. "Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19." Journal of the American Heart Association vol. 10,24 (2021): e023535. doi: https://doi.org/10.1161/JAHA.121.023535
Pan M, Vasbinder A, Anderson E, Catalan T, Shadid HR, Berlin H, Padalia K, O'Hayer P, Meloche C, Azam TU, Khaleel I, Michaud E, Blakely P, Bitar A, Huang Y, Zhao L, Pop-Busui R, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Reiser J, Eugen-Olsen J, Hayek SS. Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19. J Am Heart Assoc. 2021 Dec 21;10(24):e023535. doi: 10.1161/JAHA.121.023535. Epub 2021 Dec 10. PMID: 34889102.
Copy Download .nbib Format: NLM
Falls in individuals with type 2 diabetes; a cross-sectional study on the impact of motor dysfunction, postural instability and diabetic polyneuropathy.

Diabetic medicine : a journal of the British Diabetic Association

Khan KS, Pop-Busui R, Devantier L, Kristensen AG, Tankisi H, Dalgas U, Overgaard K, Andersen H.
PMID: 33259675
Diabet Med. 2021 Sep;38(9):e14470. doi: 10.1111/dme.14470. Epub 2020 Dec 12.

AIM: To estimate the incidence of falls in individuals with type 2 diabetes compared to healthy controls and to describe the characteristics of fallers with type 2 diabetes in relation to motor dysfunction, postural instability and diabetic polyneuropathy (DPN).METHODS:...

Cite
Khan KS, Pop-Busui R, Devantier L, et al. Falls in individuals with type 2 diabetes; a cross-sectional study on the impact of motor dysfunction, postural instability and diabetic polyneuropathy. Diabet Med. 2020;38(9):e14470doi: 10.1111/dme.14470.
Khan, K. S., Pop-Busui, R., Devantier, L., Kristensen, A. G., Tankisi, H., Dalgas, U., Overgaard, K., & Andersen, H. (2021). Falls in individuals with type 2 diabetes; a cross-sectional study on the impact of motor dysfunction, postural instability and diabetic polyneuropathy. Diabetic medicine : a journal of the British Diabetic Association, 38(9), e14470. https://doi.org/10.1111/dme.14470
Khan, Karolina S, et al. "Falls in individuals with type 2 diabetes; a cross-sectional study on the impact of motor dysfunction, postural instability and diabetic polyneuropathy." Diabetic medicine : a journal of the British Diabetic Association vol. 38,9 (2021): e14470. doi: https://doi.org/10.1111/dme.14470
Khan KS, Pop-Busui R, Devantier L, Kristensen AG, Tankisi H, Dalgas U, Overgaard K, Andersen H. Falls in individuals with type 2 diabetes; a cross-sectional study on the impact of motor dysfunction, postural instability and diabetic polyneuropathy. Diabet Med. 2021 Sep;38(9):e14470. doi: 10.1111/dme.14470. Epub 2020 Dec 12. PMID: 33259675.
Copy Download .nbib Format: NLM
Association Between Management of Continuous Subcutaneous Basal Insulin Administration and HbA1C.

Journal of diabetes science and technology

Rubin-Falcone H, Fox I, Hirschfeld E, Ang L, Pop-Busui R, Lee JM, Wiens J.
PMID: 33853374
J Diabetes Sci Technol. 2021 Apr 14;19322968211004171. doi: 10.1177/19322968211004171. Epub 2021 Apr 14.

BACKGROUND: While we expect that patients who adjust their insulin delivery algorithms between clinic visits to have better glucose control compared to those who do not, this effect has not been quantified.METHOD: This is a single-center retrospective cohort study...

Cite
Rubin-Falcone H, Fox I, Hirschfeld E, et al. Association Between Management of Continuous Subcutaneous Basal Insulin Administration and HbA1C. J Diabetes Sci Technol. 2021;19322968211004171doi: 10.1177/19322968211004171.
Rubin-Falcone, H., Fox, I., Hirschfeld, E., Ang, L., Pop-Busui, R., Lee, J. M., & Wiens, J. (2021). Association Between Management of Continuous Subcutaneous Basal Insulin Administration and HbA1C. Journal of diabetes science and technology, 19322968211004171. https://doi.org/10.1177/19322968211004171
Rubin-Falcone, Harry, et al. "Association Between Management of Continuous Subcutaneous Basal Insulin Administration and HbA1C." Journal of diabetes science and technology vol. (2021): 19322968211004171. doi: https://doi.org/10.1177/19322968211004171
Rubin-Falcone H, Fox I, Hirschfeld E, Ang L, Pop-Busui R, Lee JM, Wiens J. Association Between Management of Continuous Subcutaneous Basal Insulin Administration and HbA1C. J Diabetes Sci Technol. 2021 Apr 14;19322968211004171. doi: 10.1177/19322968211004171. Epub 2021 Apr 14. PMID: 33853374.
Copy Download .nbib Format: NLM
Sexual dysfunction in women with type 1 diabetes in Norway: A cross-sectional study on the prevalence and associations with physical and psychosocial complications.

Diabetic medicine : a journal of the British Diabetic Association

Haugstvedt A, Jørgensen J, Strandberg RB, Nilsen RM, Haugstvedt JF, Pop-Busui R, Søfteland E.
PMID: 34596251
Diabet Med. 2021 Oct 01;e14704. doi: 10.1111/dme.14704. Epub 2021 Oct 01.

AIM: To estimate the prevalence of sexual dysfunction in women with type 1 diabetes (T1D) compared with women without diabetes and to analyse associations between sexual dysfunction and the presence of chronic physical diabetes complications, diabetes distress and depression...

Cite
Haugstvedt A, Jørgensen J, Strandberg RB, et al. Sexual dysfunction in women with type 1 diabetes in Norway: A cross-sectional study on the prevalence and associations with physical and psychosocial complications. Diabet Med. 2021;e14704doi: 10.1111/dme.14704.
Haugstvedt, A., Jørgensen, J., Strandberg, R. B., Nilsen, R. M., Haugstvedt, J. F., Pop-Busui, R., & Søfteland, E. (2021). Sexual dysfunction in women with type 1 diabetes in Norway: A cross-sectional study on the prevalence and associations with physical and psychosocial complications. Diabetic medicine : a journal of the British Diabetic Association, e14704. https://doi.org/10.1111/dme.14704
Haugstvedt, Anne, et al. "Sexual dysfunction in women with type 1 diabetes in Norway: A cross-sectional study on the prevalence and associations with physical and psychosocial complications." Diabetic medicine : a journal of the British Diabetic Association vol. (2021): e14704. doi: https://doi.org/10.1111/dme.14704
Haugstvedt A, Jørgensen J, Strandberg RB, Nilsen RM, Haugstvedt JF, Pop-Busui R, Søfteland E. Sexual dysfunction in women with type 1 diabetes in Norway: A cross-sectional study on the prevalence and associations with physical and psychosocial complications. Diabet Med. 2021 Oct 01;e14704. doi: 10.1111/dme.14704. Epub 2021 Oct 01. PMID: 34596251.
Copy Download .nbib Format: NLM
Diabetic Peripheral Neuropathy and Urological Complications in Type 1 Diabetes: Findings From the Epidemiology of Diabetes Interventions and Complications Study.

Diabetes care

Pop-Busui R, Braffett BH, Wessells H, Herman WH, Martin CL, Jacobson AM, Sarma AV.
PMID: 34728530
Diabetes Care. 2021 Nov 02; doi: 10.2337/dc21-1276. Epub 2021 Nov 02.

OBJECTIVE: To evaluate associations between diabetic peripheral neuropathy (DPN) and urological complications in men and women with type 1 diabetes (T1D).RESEARCH DESIGN AND METHODS: Measurements of DPN at Epidemiology of Diabetes Intervention and Complications (EDIC) years 1, 14, and...

Cite
Pop-Busui R, Braffett BH, Wessells H, et al. Diabetic Peripheral Neuropathy and Urological Complications in Type 1 Diabetes: Findings From the Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care. 2021;doi: 10.2337/dc21-1276.
Pop-Busui, R., Braffett, B. H., Wessells, H., Herman, W. H., Martin, C. L., Jacobson, A. M., Sarma, A. V. (2021). Diabetic Peripheral Neuropathy and Urological Complications in Type 1 Diabetes: Findings From the Epidemiology of Diabetes Interventions and Complications Study. Diabetes care, . https://doi.org/10.2337/dc21-1276
Pop-Busui, Rodica, et al. "Diabetic Peripheral Neuropathy and Urological Complications in Type 1 Diabetes: Findings From the Epidemiology of Diabetes Interventions and Complications Study." Diabetes care vol. (2021). doi: https://doi.org/10.2337/dc21-1276
Pop-Busui R, Braffett BH, Wessells H, Herman WH, Martin CL, Jacobson AM, Sarma AV. Diabetic Peripheral Neuropathy and Urological Complications in Type 1 Diabetes: Findings From the Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care. 2021 Nov 02; doi: 10.2337/dc21-1276. Epub 2021 Nov 02. PMID: 34728530.
Copy Download .nbib Format: NLM
Differences in Inflammation, Treatment, and Outcomes Between Black and Non-Black Patients Hospitalized for COVID-19: A Prospective Cohort Study.

The American journal of medicine

Azam TU, Berlin H, Anderson E, Pan M, Shadid HR, Padalia K, O'Hayer P, Meloche C, Feroze R, Michaud E, Launius C, Blakely P, Bitar A, Willer C, Pop-Busui R, Carethers JM, Hayek SS.
PMID: 34793753
Am J Med. 2021 Nov 16; doi: 10.1016/j.amjmed.2021.10.026. Epub 2021 Nov 16.

PURPOSE: Racial disparities in coronavirus disease 2019 (COVID-19) outcomes have been described. We sought to determine whether differences in inflammatory markers, use of COVID-19 therapies, enrollment in clinical trials, and in-hospital outcomes contribute to racial disparities between Black and...

Cite
Azam TU, Berlin H, Anderson E, et al. Differences in Inflammation, Treatment, and Outcomes Between Black and Non-Black Patients Hospitalized for COVID-19: A Prospective Cohort Study. Am J Med. 2021;doi: 10.1016/j.amjmed.2021.10.026.
Azam, T. U., Berlin, H., Anderson, E., Pan, M., Shadid, H. R., Padalia, K., O'Hayer, P., Meloche, C., Feroze, R., Michaud, E., Launius, C., Blakely, P., Bitar, A., Willer, C., Pop-Busui, R., Carethers, J. M., & Hayek, S. S. (2021). Differences in Inflammation, Treatment, and Outcomes Between Black and Non-Black Patients Hospitalized for COVID-19: A Prospective Cohort Study. The American journal of medicine, . https://doi.org/10.1016/j.amjmed.2021.10.026
Azam, Tariq U, et al. "Differences in Inflammation, Treatment, and Outcomes Between Black and Non-Black Patients Hospitalized for COVID-19: A Prospective Cohort Study." The American journal of medicine vol. (2021). doi: https://doi.org/10.1016/j.amjmed.2021.10.026
Azam TU, Berlin H, Anderson E, Pan M, Shadid HR, Padalia K, O'Hayer P, Meloche C, Feroze R, Michaud E, Launius C, Blakely P, Bitar A, Willer C, Pop-Busui R, Carethers JM, Hayek SS. Differences in Inflammation, Treatment, and Outcomes Between Black and Non-Black Patients Hospitalized for COVID-19: A Prospective Cohort Study. Am J Med. 2021 Nov 16; doi: 10.1016/j.amjmed.2021.10.026. Epub 2021 Nov 16. PMID: 34793753; PMCID: PMC8592847.
Copy Download .nbib Format: NLM
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19.

Journal of the American Heart Association

Pan M, Vasbinder A, Anderson E, Catalan T, Shadid HR, Berlin H, Padalia K, O'Hayer P, Meloche C, Azam TU, Khaleel I, Michaud E, Blakely P, Bitar A, Huang Y, Zhao L, Pop-Busui R, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Reiser J, Eugen-Olsen J, Hayek SS.
PMID: 34889102
J Am Heart Assoc. 2021 Dec 10;e023535. doi: 10.1161/JAHA.121.023535. Epub 2021 Dec 10.

Background Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ACEi/ARB) is thought to affect COVID-19 through modulating levels of angiotensin-converting enzyme 2, the cell entry receptor for SARS-CoV2. We sought to assess the association between ACEi/ARB, biomarkers of...

Cite
Pan M, Vasbinder A, Anderson E, et al. Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19. J Am Heart Assoc. 2021;e023535doi: 10.1161/JAHA.121.023535.
Pan, M., Vasbinder, A., Anderson, E., Catalan, T., Shadid, H. R., Berlin, H., Padalia, K., O'Hayer, P., Meloche, C., Azam, T. U., Khaleel, I., Michaud, E., Blakely, P., Bitar, A., Huang, Y., Zhao, L., Pop-Busui, R., Loosen, S. H., Chalkias, A., Tacke, F., Giamarellos-Bourboulis, E. J., Reiser, J., Eugen-Olsen, J., Hayek, S. S. (2021). Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19. Journal of the American Heart Association, e023535. https://doi.org/10.1161/JAHA.121.023535
Pan, Michael, et al. "Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19." Journal of the American Heart Association vol. (2021): e023535. doi: https://doi.org/10.1161/JAHA.121.023535
Pan M, Vasbinder A, Anderson E, Catalan T, Shadid HR, Berlin H, Padalia K, O'Hayer P, Meloche C, Azam TU, Khaleel I, Michaud E, Blakely P, Bitar A, Huang Y, Zhao L, Pop-Busui R, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Reiser J, Eugen-Olsen J, Hayek SS. Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19. J Am Heart Assoc. 2021 Dec 10;e023535. doi: 10.1161/JAHA.121.023535. Epub 2021 Dec 10. PMID: 34889102.
Copy Download .nbib Format: NLM
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19.

Journal of the American Heart Association

Pan M, Vasbinder A, Anderson E, Catalan T, Shadid HR, Berlin H, Padalia K, O'Hayer P, Meloche C, Azam TU, Khaleel I, Michaud E, Blakely P, Bitar A, Huang Y, Zhao L, Pop-Busui R, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Reiser J, Eugen-Olsen J, Hayek SS.
PMID: 34889102
J Am Heart Assoc. 2021 Dec 10;e023535. doi: 10.1161/JAHA.121.023535. Epub 2021 Dec 10.

Background Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ACEi/ARB) is thought to affect COVID-19 through modulating levels of angiotensin-converting enzyme 2, the cell entry receptor for SARS-CoV2. We sought to assess the association between ACEi/ARB, biomarkers of...

Cite
Pan M, Vasbinder A, Anderson E, et al. Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19. J Am Heart Assoc. 2021;e023535doi: 10.1161/JAHA.121.023535.
Pan, M., Vasbinder, A., Anderson, E., Catalan, T., Shadid, H. R., Berlin, H., Padalia, K., O'Hayer, P., Meloche, C., Azam, T. U., Khaleel, I., Michaud, E., Blakely, P., Bitar, A., Huang, Y., Zhao, L., Pop-Busui, R., Loosen, S. H., Chalkias, A., Tacke, F., Giamarellos-Bourboulis, E. J., Reiser, J., Eugen-Olsen, J., Hayek, S. S. (2021). Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19. Journal of the American Heart Association, e023535. https://doi.org/10.1161/JAHA.121.023535
Pan, Michael, et al. "Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19." Journal of the American Heart Association vol. (2021): e023535. doi: https://doi.org/10.1161/JAHA.121.023535
Pan M, Vasbinder A, Anderson E, Catalan T, Shadid HR, Berlin H, Padalia K, O'Hayer P, Meloche C, Azam TU, Khaleel I, Michaud E, Blakely P, Bitar A, Huang Y, Zhao L, Pop-Busui R, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Reiser J, Eugen-Olsen J, Hayek SS. Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19. J Am Heart Assoc. 2021 Dec 10;e023535. doi: 10.1161/JAHA.121.023535. Epub 2021 Dec 10. PMID: 34889102.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 46 entries